Martin Karlsson

ORCID: 0000-0002-1707-9398
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Blood transfusion and management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Blood properties and coagulation
  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Cardiac and Coronary Surgery Techniques
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Intensive Care Unit Cognitive Disorders
  • Heart Failure Treatment and Management
  • Cardiac Valve Diseases and Treatments
  • Cardiac Health and Mental Health
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Obstructive Sleep Apnea Research
  • Lipoproteins and Cardiovascular Health
  • Frailty in Older Adults
  • Blood Coagulation and Thrombosis Mechanisms
  • Cardiac Arrest and Resuscitation
  • Health Systems, Economic Evaluations, Quality of Life
  • Health disparities and outcomes
  • Primary Care and Health Outcomes
  • Cardiovascular and Diving-Related Complications
  • Diagnosis and Treatment of Venous Diseases
  • Dementia and Cognitive Impairment Research

University of Gothenburg
2010-2024

Skaraborg Hospital
2014-2023

Sahlgrenska University Hospital
2008-2023

Sjukhuset i Lidköping
2019-2022

Chalmers University of Technology
2008

Summary It has been suggested that preoperative fibrinogen plasma concentration is independently associated to postoperative blood loss after cardiac surgery.Theoretically, prophylactic infusion of concentrate may thus reduce bleeding, but this not previously investigated. Twenty elective coronary artery bypass graft (CABG) patients with levels <3.8 g/l were included in a prospective randomised pilot study. Patients receive an 2 g (FIB group) or no before surgery (control group). Primary...

10.1160/th08-09-0587 article EN Thrombosis and Haemostasis 2009-01-01

BACKGROUND: Early identification of patients with increased risk excessive bleeding and transfusion after cardiac surgery offers the possibility to initiate countermeasures. Fibrinogen is a key protein in coagulation cascade thus potential biomarker for bleeding. We investigated relationship between preoperative fibrinogen plasma concentration postoperative coronary artery bypass grafting (CABG). STUDY DESIGN AND METHODS: A total 170 (mean age, 67 ± 9 years; 75% men) undergoing isolated CABG...

10.1111/j.1537-2995.2008.01827.x article EN Transfusion 2008-07-24

To evaluate the long-term use of secondary prevention medications [statins, β-blockers, renin-angiotensin-aldosterone system (RAAS) inhibitors, and platelet inhibitors] after coronary artery bypass grafting (CABG) association between medication mortality.

10.1093/eurheartj/ehz714 article EN cc-by-nc European Heart Journal 2019-10-01

To determine the discriminative accuracy and calibration of EuroSCORE II in relation to age, sex, surgical risk a large nationwide coronary artery bypass grafting (CABG) cohort.All 14,118 patients undergoing isolated CABG Sweden during 2012-2017 were included. Individual patient data taken from SWEDEHEART registry. Patients divided by age (< 60, 60-69, 70-79, ≥ 80 years), (low: < 4%, intermediate: 4-8%, high: > 8%). Discriminative was determined area under receiver operating characteristic...

10.1186/s13019-023-02141-4 article EN cc-by Journal of Cardiothoracic Surgery 2023-01-19

Background Little is known of the impact social factors on mortality after coronary artery bypass grafting ( CABG ). We explored sex- and age-specific associations between risk marital status, income, education. Methods Results This population-based register study included 110 742 patients (21.3% women) from SWEDEHEART registry (Swedish Web-system for Enhancement Development Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies) operated 1992 2015. Cox regression...

10.1161/jaha.118.011490 article EN cc-by-nc-nd Journal of the American Heart Association 2019-03-11

Objective: We have recently reported that prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass grafting (CABG) surgery. Because for the first time was administered to patients without hereditary deficiency or ongoing bleeding, a detailed analysis of effects concentrate on biomarkers coagulation, fibrinolysis, and platelet function performed. Methods: Twenty CABG with preoperative plasma levels &lt;3.8 g/L were included in prospective study. Patients randomized 2 g...

10.1177/1076029610366437 article EN Clinical and Applied Thrombosis/Hemostasis 2010-06-07

Background Low income and short education have been found to be independently associated with inferior survival after coronary artery bypass grafting ( CABG ), whereas the use of secondary prevention medications is improved survival. We investigated whether underusage contributes long‐term in patients a low education. Methods Results Patients who underwent Sweden between 2006 2015 survived at least 6 months discharge (n=28 448) were included population‐based cohort study. Individual patient...

10.1161/jaha.119.015491 article EN cc-by-nc-nd Journal of the American Heart Association 2020-03-02

We examined the long-term risk of dementia after coronary artery bypass grafting (CABG) in relation to age and sex.All CABG patients Sweden 1992-2015 (n = 111,335), matched controls 222,396) were included a population-based study. Adjusted hazard ratios (aHR) for all-cause dementia, vascular Alzheimer's disease calculated.There was no difference between control subjects (aHR 0.98 [95% confidence interval 0.95 1.02]). <65 years 65 74 had higher 1.29 [1.17-1.42] 1.08 [1.02-1.13],...

10.1002/alz.12251 article EN cc-by-nc-nd Alzheimer s & Dementia 2021-03-04

Excessive bleeding leading to re-exploration is a severe complication of cardiac surgical procedures, associated with early postoperative morbidity and mortality. Less known about the long-term outcome these patients. We evaluated impact after surgery on peri- mortality, as well in well-defined nationwide population.In this retrospective study, 48 060 consecutive patients undergoing coronary artery bypass grafting (CABG) and/or valve from 2006 2015 were analysed. Multivariable logistic...

10.1093/ejcts/ezac208 article EN European Journal of Cardio-Thoracic Surgery 2022-03-18

Abstract Background We investigated whether fibrinogen concentrate administration to bleeding patients is associated with an increased risk of thromboembolic complications and death. Methods All consecutive who underwent first-time cardiac surgery at Sahlgrenska University Hospital from 2009 2014 were included. Patients, had received concentrate, compared those not concentrate. The primary endpoint was a composite death within 1 year after surgery. Secondary endpoints included the mortality...

10.1055/s-0039-3402759 article EN Thrombosis and Haemostasis 2020-01-15

To investigate the importance of blood sampling conditions for multiple electrode platelet aggregometry (MEA) in cardiac surgery patients.Eighty-one patients undergoing first time CABG were included three prospective, observational studies. MEA was used to analyze aggregability after addition adenosine-diphosphate (ADP) or thrombin activating peptide 6 (TRAP). In substudy 1, hirudin and citrate tubes compared. 2, samples from peripheral vein, central venous catheter, radial artery compared...

10.3109/14017431.2012.743672 article EN Scandinavian Cardiovascular Journal 2012-10-25

Fibrinogen concentrate is used clinically to improve hemostasis in bleeding patients. We investigated and compared the efficacy of three commercially available fibrinogen concentrates clot strength blood samples from cardiac surgery patients.Postoperative were collected 23 Samples each divided into four vials, supplemented with 1.125 mg one (RiaSTAP® , Fibryga® FibCLOT® ), or placebo. The dose corresponded 2.5 g per 70 kg body weight. Clot after supplementation was assessed duplicate...

10.1111/aas.13967 article EN cc-by-nc-nd Acta Anaesthesiologica Scandinavica 2021-08-09

Previous reports suggest that betablockers appear non-beneficial after surgical aortic valve replacement (SAVR). This study aims to clarify the associations between and long-term outcome SAVR.

10.1093/ejcts/ezae365 article EN cc-by-nc European Journal of Cardio-Thoracic Surgery 2024-10-01

Obstructive sleep apnea (OSA) is associated with atrial fibrillation (AF) in cardiac cohorts. Less known regarding the magnitude of this association a clinic cohort vs. without excessive daytime sleepiness (EDS).

10.1016/j.sleep.2023.09.012 article EN cc-by Sleep Medicine 2023-09-28

Summary Objectives To investigate if supplementation with fibrinogen concentrate to blood samples collected after tranexamic acid administration improve clot formation more than what can be achieved in the absence of acid. Background It is not known combination and has additional effects individually. Methods Four were from 15 coronary artery bypass patients. Two before surgery, 2 g was administered. The preoperative diluted haematocrit 21%. a second dose Fibrinogen corresponding 3 70‐kg...

10.1111/tme.12604 article EN Transfusion Medicine 2019-05-22

(Abstracted from Br J Anaesth,116(2):208–214, 2016) Excessive bleeding after cardiac surgery is a serious complication associated with increased morbidity and mortality linked to number of causes, including low plasma fibrinogen concentration. Fibrinogen key factor in coagulation.

10.1097/sa.0000000000000263 article EN Survey of Anesthesiology 2016-11-18

10.1111/j.1537-2995.2009.02297.x article Transfusion 2009-08-26

Abstract Background Previous studies investigating the association between coronary artery bypass grafting (CABG) and risk for dementia show conflicting results. Purpose To compare long-term in CABG patients to matched individuals general population, identify independent predictors developing after CABG. Methods Data from SWEDEHEART registry three other mandatory national registries were merged all who underwent isolated Sweden 1992 2015 (n=111.335) with an age- sex-matched control...

10.1093/ehjci/ehaa946.1364 article EN European Heart Journal 2020-11-01

Abstract BACKGROUND To determine the discriminative accuracy and calibration of EuroSCORE II in relation to age, sex, surgical risk a large nationwide coronary artery bypass grafting (CABG) cohort. METHODS All 14118 patients undergoing isolated CABG Sweden during 2012–2017 were included. Individual patient data taken from SWEDEHEART registry. Patients divided by age (&lt;60, 60–69, 70–79, ≥80 years), (low: &lt;4%, intermediate: 4–8%, high: &gt;8%). Discriminative was determined area under...

10.21203/rs.3.rs-2073914/v1 preprint EN cc-by Research Square (Research Square) 2022-09-22
Coming Soon ...